Catechol dehydroxylation is a central chemical transformation in the gut microbial 18 metabolism of plant-and host-derived small molecules. However, the molecular basis for this 19 transformation and its distribution among gut microorganisms are poorly understood. Here, we 20 characterize a molybdenum-dependent enzyme from the prevalent human gut bacterium 21
Introduction 35
The human gastrointestinal tract is one of the densest microbial habitats on Earth. 36
Possessing 150-fold more genes than the human genome, the trillions of organisms that make up 37 this community (the human gut microbiota) harbor metabolic capabilities that expand the range of 38 chemistry taking place in the body (1-3). Microbial metabolism affects host nutrition and health 39 by breaking down otherwise inaccessible carbohydrates, biosynthesizing essential vitamins, and 40 transforming endogenous and exogenous small molecules into bioactive metabolites (4) . Gut 41 microbial activities can also vary significantly between individuals, affecting the toxicity and 42 efficacy of drugs (5) (6) (7) (8) (9) , susceptibility to infection (10) (11) , and host metabolism (12) (13) . To 43 decipher the biological roles of gut microbial metabolism, it is critical that we uncover the enzymes 44 responsible for prominent transformations. This will not only increase the information gained from 45 microbiome sequencing data but may also illuminate strategies for manipulating and studying 46 microbial functions. Yet, the vast majority of gut microbial metabolic reactions have not yet been 47 linked to specific enzymes. 48 A prominent but poorly understood gut microbial activity is the dehydroxylation of 49 catechols (1,2-dihydroxylated aromatic rings), a structural motif commonly found in a diverse 50
This result prompted us to explore whether the transcriptional regulation of Dadh displayed 96 similar specificity. Thus, we cultured E. lenta A2 in the presence of a subset of the dopamine 97 analogs that we had tested in the previous experiment, measured dehydroxylation using liquid 98 chromatography-mass spectometry (LC-MS), and profiled the global transcriptome using RNA-99 seq. Consistent with the biochemical data, we found that the regulation of dadh was also specific 100 for the catecholamine scaffold ( Fig. 1F, table S3 ). While the catecholamines dopamine and 101 norepinephrine induced dadh expression and were dehydroxylated by E. lenta, analogs lacking the 102 catechol (analog 1 in Fig. 1D ) or having a shorter side chain (analog 9 in Fig. 1D ) did not induce 103 a transcriptional or metabolic response ( Fig. 1F, table S3 ) (29) . Together with our biochemical 104 results, these transcriptional data suggest that Dadh may have evolved for the purpose of 105 catecholamine neurotransmitter metabolism in E. lenta. We propose that dopamine is an 106 endogenous substrate of this enzyme, because it was the best substrate both in vitro and in vivo, 107 induced the highest levels of expression in E. lenta, and is produced at substantial levels by the 108 human gastrointestinal tract (32) . 109
In addition to uncovering a preference for the catecholamine scaffold, the substrate scope of 110 Dadh in vitro reveal potential mechanistic distinctions between this enzyme and the only other 111 biochemically characterized reductive aromatic dehydroxylase, 4-hydroxybenzoyl CoA reductase 112 (4-HCBR) (35) . 4-HCBR is a distinct molybdenum dependent-enzyme containing a monomeric 113 molybdopterin co-factor that uses a Birch reduction-like mechanism to remove a single aromatic 114 hydroxyl group from 4-hydroxybenzoyl CoA. While 4-HCBR requires an electron-withdrawing 115 thioester group to stabilize radical anion intermediates (33) , Dadh does not require an electron-116 withdrawing substituent and can tolerate additional electron-donating hydroxyl groups ( Fig. 1D  117 and E, analogs 11-13). We preliminarily propose a mechanism for Dadh in which the dopamine p-118 hydroxyl group coordinates to the molybdenum center. This could be followed by tautomerization 119 of the m-hydroxyl group to a ketone with protonation of the adjacent carbon atom. Oxygen atom 120 transfer to molybdenum could be accompanied by rearomatization, providing the dehydroxylated 121 product ( fig. S2 ). Our proposal is consistent with the postulated mechanisms of other oxygen 122 transfer reactions catalyzed by bis-MGD enzymes (34, 35) . 
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Dadh towards a panel of physiologically relevant catechol substrates. Enzyme (0.1 µM) was 130 incubated with substrate (500 µM) for 22 hours at room temperature, followed by analysis using 131 LC-MS. Bars represent the mean ± the standard error (SEM) of three biological replicates. See 132 table S1 for the full chemical structures. D) Dopamine analogs evaluated in this study. E) Activity 133 of natively purified Dadh towards dopamine analogs in C). Enzyme (0.1 µM) was incubated with 134 substrate (500 µM) for 22 hours at room temperature, followed by analysis using LC-MS. Bars 135 represent the mean ± the SEM of three biological replicates. See table S2 for the full chemical 136 structures. F) Transcriptional induction and whole-cell dehydroxylation activity of E. lenta A2 in 137 response to dopamine and a subset of dopamine analogs (500 µM each). Transcriptional induction 138 was assessed using RNA-seq, with the fold induction shown on the x-axis (log2foldchange>4, 139 FDR<0.01). To assess whole-cell metabolism, E. lenta was grown anaerobically for 48 hours in 140 BHI medium with 500 µM of each substrate, and the culture supernatant was analyzed for 141 dehydroxylated metabolites using a colorimetric assay or LC-MS. RNA-sequencing data represent 142 the log2fold change of triplicate experiments. The metabolism data represent the mean ± the SEM 143 of three biological replicates. Error bars are not visible because they are smaller than the datapoint. 144 145
Dopamine promotes gut bacterial growth by serving as an alternative electron acceptor 146
The specificity of Dadh for dopamine suggested this metabolic activity might have an 147 important physiological role in E. lenta. We noted the chemical parallels between catechol 148 dehydroxylation and reductive dehalogenation, a metabolic process in which halogenated 149 aromatics serve as alternative electron acceptors in certain environmental bacteria (35) . This 150 insight inspired the hypothesis that dopamine dehydroxylation could serve a similar role in 151 anaerobic respiration for gut bacteria. While we observed no growth benefit when E. lenta was 152 grown in complex BHI medium containing dopamine ( fig. S3 ), we found that including dopamine 153 in a minimal medium lacking electron acceptors (basal medium) increased the endpoint optical 154 density of E. lenta cultures ( Fig. 2A ). This growth-promoting effect was only observed in 155 dopamine-metabolizing E. lenta strains, as non-metabolizing strains that express an apparently 156 inactive enzyme (29) did not gain a growth advantage ( Fig. 2A, fig. S4 , and table S4). The effect 157 of dopamine on E. lenta contrasts with recent studies of digoxin, a drug that is reduced by E. lenta 158 without impacting growth in the same medium (6) . 159
We further investigated the relationship between dopamine and bacterial growth in the 160 metabolizing strain E. lenta A2. The growth increase observed in response to dopamine was dose-161 dependent ( fig. S5 ), mirrored the effects of the known electron acceptors DMSO and nitrate (6, 162 36) , and did not derive from the product of dopamine dehydroxylation, m-tyramine ( Fig. 2B ). 163
Additionally, the growth benefit was directly tied to dopamine dehydroxylation. Inclusion of 164 tungstate in the growth medium, which inactivates the big-MGD cofactor of Dadh, blocked 165 metabolism and inhibited the growth increase. In contrast, inclusion of molybdate in the growth 166 medium did not impact growth or metabolism ( Fig. 2B and fig. S6 ). Molybdate and tungstate alone 167 did not impact E. lenta A2 growth in the basal medium ( fig. S7 ). Taken together, these results 168 indicate that active metabolism of dopamine provides a growth advantage to E. lenta, likely by 169 serving as an alternative electron acceptor. 170
We next examined whether dopamine could promote E. lenta growth in microbial 171 communities. First, we competed dopamine metabolizing and non-metabolizing E. lenta strains in 172 minimal medium. E. lenta is genetically intractable, preventing the use of engineered plasmids 173 encoding defined fluorescence or antibiotic resistance as markers of strain identity. Instead, we 174 took advantage of intrinsic differences in tetracyline (Tet) resistance to differentiate the closely 175 related strains in pairwise competitions (37) . Inclusion of dopamine in growth medium 176 significantly increased the proportion of the metabolizer relatively to the non-metabolizer in this 177 competition experiment (p<0.001, two-tailed unpaired t-test) ( Fig. 2C and fig. S8 ). This was driven 178 by the growth increase of the metabolizer rather than a decrease in the non-metabolizer ( Fig Next, we explored the impact of dopamine on Tet-resistant E. lenta in the presence of a 181 defined bacterial community representing the major phylogenetic diversity in the human gut ( Fig.  182 2D and table S4) (38, 39) . We found that including dopamine in the medium boosted the growth 183 of metabolizers by an order of magnitude while non-metabolizing strains did not gain a growth 184 advantage ( Fig. 2D ). Finally, we evaluated the impact of dopamine on E. lenta strains present in 185 complex human gut microbiotas. We cultured fecal samples from 24 unrelated subjects ex vivo in 186 the presence and absence of dopamine and used qPCR to assess the abundance of metabolizing E. 187 lenta strains and dadh. Strikingly, both dadh and E. lenta significantly increased by an order of 188 magnitude in cultures containing dopamine (p<0.005, two-tailed unpaired t-test) ( Fig. 2E) 
S9). We also amplified the full length dadh gene from these cultures and sequenced the region 190 harboring the SNP that distinguishes metabolizing and non-metabolizing strains (29) . These assays 191 indicated that the increase in dadh abundance in the complex communities was accompanied by a 192 significant shift from a mixture of inactive and active dadh variants to a dominance of the 193 metabolizing R506 variant (p<0.01, Fisher's exact test) ( Fig. 2F ). Overall, these results show that 194 dopamine dehydroxylation increases the fitness of metabolizing E. lenta strains in both defined 195 and complex microbial communities. vivo. Samples from unrelated individuals (n = 24) were grown for 72 hours at 37 ºC in basal 218 medium containing 10 mM acetate with or without dopamine and qPCR was used to assess 219 abundance of dadh. Two individuals were excluded from this analysis as they did not demonstrate 220 quantitative metabolism of dopamine after incubation. Each point represents a different individual. 221
Lines connect data from the same individual between the two conditions. (***P<0.001, two-tailed 222 unpaired t-test). F) Counts of dadh variants in the presence and absence of dopamine. The same 223 gDNA used in E) was used to amplify full-length dadh and determine the SNP status at position 224 506 using Sanger sequencing. As in panel E, two individuals were removed prior to analysis as 225 they did not demonstrate quantitative metabolism of dopamine after incubation. In addition, one 226 individual was not included in this analysis due to failure of obtaining high quality sequencing 227 data. (**P<0.01, Fisher's exact test). 228
A screen of human gut Actinobacteria uncovers dehydroxylation of host and plant-derived 230 catechols 231
Having uncovered Dadh's specialized role in gut bacterial dopamine metabolism, we sought 232 to identify strains and enzymes that could dehydroxylate other catechol substrates. Among human 233 gut bacteria, only Eggerthella and closely related members of the Actinobacteria phylum have 234 been reported to perform catechol dehydroxylation. For example, Eggerthella metabolizes 235 dopamine and (+)-catechin (40) , while related Gordonibacter species dehydroxylate ellagic acid 236 (41) and a lignan derivative in the multi-step biosynthesis of the anti-cancer metabolite enterodiol 237 (42) . These reports suggest that Actinobacteria could be a promising starting point to identify new 238 dehydroxylating strains and enzymes. Thus, we assembled a library of related gut Actinobacteria 239 (37) and screened these strains individually (n=3 replicates) for metabolism of a range of 240 compounds relevant in the human gut, including plant-and host-derived small molecules, bacterial 241 siderophores, and FDA-approved catecholic drugs (14-16) (table S5) ( Fig. 3A ). We initially used 242 a colorimetric assay that detects catechols to assess metabolism, which allowed us to rapidly screen 243 for potential catechol depletion across the collection of 25 strains and 19 compounds of interest. 244
We observed complete depletion of several host and diet-derived catechols in this initial screen 245 (fig. S10). We chose to focus on the dehydroxylation of hydrocaffeic acid, (+)-catechin, and 246 DOPAC for further characterization, repeating the incubations with these compounds and using 247 LC-MS/MS to confirm the production of dehydroxylated metabolites. This analysis confirmed that 248 both DOPAC and hydrocaffeic acid are directly dehydroxylated by members of this library, while 249 (+)-catechin undergoes benzyl ether reduction followed by dehydroxylation to give the ring-250 opened derivative 2, as has been observed previously (40) ( Fig. 3 and table S6). While (+)-catechin 251 metabolism has been previously linked to Eggerthella (40) , the dehydroxylation of DOPAC and 252 hydrocaffeic acid has only been previously observed by complex gut microbiota communities 253 (17, 21) . The variability in these activities across closely related gut bacterial strains suggests that 254 different enzymes might dehydroxylate different catechols. 255 We next sought to determine the molecular basis of the dehydroxylation reactions examined 277 above. To test the hypothesis that dehydroxylation resulted from specific rather than promiscuous 278 enzymes, we first established that dehydroxylation is an inducible activity in Gordonibacter and 279
Eggerthella strains ( fig. S11 ). This allowed us to use cell lysates as a proxy for transcriptional 280 induction and a means of examining dehydroxylase activity. We grew E. lenta A2 in the presence 281 of (+)-catechin, hydrocaffeic acid, and dopamine, and grew G. pamelaeae 3C in the presence of 282 DOPAC. We then screened each anaerobic lysate for its activity towards all of these substrates. 283
Consistent with our prediction, each lysate quantitively dehydroxylated only the catechol substrate 284 with which the strain had been grown. While the E. lenta lysates did not display any promiscuity 285 ( Fig. 4A ), cell lysate from G. pamelaeae grown in the presence of DOPAC displayed low activity 286 (<40%) towards hydrocaffeic acid, which structurally resembles DOPAC (Fig. 4B ). Overall, these 287 results suggest that different catechol substrates induce the expression of distinct dehydroxylase 288 enzymes that are specific in their biochemical activity and transcriptional regulation. We expected 289 that these enzymes would be molybdenum-dependent like Dadh, as these are the only types of 290 enzymes known to be capable of aromatic dehydroxylation (29, 31, (33) (34) . 291
To identify the molecular basis of (+)-catechin and hydrocaffeic acid dehydroxylation in E. 292 lenta A2, we turned to RNA-seq, an approach that we successfully used previously to identify the 293 dopamine dehydroxylase (29) . We grew E. lenta A2 to early exponential phase and then added 294 each catechol substrate, harvesting the cells after 1.5 hours of induction. Hydrocaffeic acid and 295 (+)-catechin each upregulated a number of genes (25 and 41, respectively), including two predicted 296 molybdenum-dependent enzymes (tables S7 and S8). While one of these predicted molybdenum-297 dependent enzymes was among the highest upregulated genes in response to each substrate (450-298 fold induced in response to catechin, >2000-fold with hydrocaffeic acid), the other enzyme was 299 only 3-fold induced relative to the vehicle. Thus, we propose that the highest upregulated 300 molybdenum-dependent enzyme in each dataset is the most reasonable candidate dehydroxylase. 301
The enzyme upregulated in response to hydrocaffeic acid (Elenta-A2_02815) shared 35.3% amino 302 acid identity with Dadh, while the enzyme upregulated in response to (+)-catechin shared 50.9% 303 amino acid identity with Dadh (tables S7-S9). 304
To evaluate the involvement of a molybdenum enzyme in each dehydroxylation reaction, we 305 cultured E. lenta in the presence of tungstate, which inactivates the metallocofactor (29, 44) . As 306 with dopamine dehydroxylation, tungstate inhibited dehydroxylation of (+)-catechin and 307 hydrocaffeic acid by E. lenta A2 without inhibiting growth in the rich BHI medium, suggesting 308 these activities are indeed molybdenum dependent ( Fig 4C-E and fig. S12 ). Tungstate did not 309 inhibit benzyl ether reduction of (+)-catechin, indicating this step is performed by a distinct 310 enzyme ( fig. S13 ). Finally, we found that the distribution of the genes encoding these the putative 311 hydrocaffeic acid and (+)-catechin dehydroxylating enzymes across closely related Eggerthella 312 strains correlated with the ability of these organisms to metabolize each substrate (Fig. 4F) We next sought to identify the enzyme responsible for dehydroxylation of DOPAC in G. 319 pamelaeae 3C. We added DOPAC to G. pamelaeae 3C cultures at mid-exponential phase and 320 harvested cells after 3 hours of induction when the cultures had reached early stationary phase. In 321 this experimental setup, G. pamelaeae 3C upregulated 99 different genes, including four distinct 322 molybdenum-dependent enzyme-encoding genes (table S10). One of these genes (C1877_13905) 323 was among the highest upregulated genes across the dataset (>1700-fold induced). To further 324 explore the association between this gene and DOPAC dehydroxylation, we repeated the RNA-325 seq experiment, growing G. pamelaeae 3C in the presence of DOPAC from the time of inoculation 326 and then harvesting cells in mid-exponential phase as soon we could detect metabolism (12 hours 327 of total growth), In this experiment, the same molybdenum-dependent enzyme-encoding gene 328 (C1877_13905) that we observed highly upregulated in our first experiment (table S11) was among 329 the highest upregulated genes. The only two other molybdenum-dependent enzymes induced in 330 this experiment were expressed at order magnitude lower levels (2-fold induced), making the 331 highest upregulated molybdenum-dependent enzyme observed across both datasets a reasonable 332 candidate DOPAC dehydroxylase. 333
This assignment is also supported by comparative genomics. First, the presence of the gene 334 encoding this candidate molybdenum enzyme correlated with DOPAC dehydroxylation among 335 members of our gut Actinobacterial library (Fig. 4F ). Consistent with our lysate assays, those 336 organisms harboring the putative DOPAC dehydroxylase also had activity towards hydrocaffeic 337 acid, which could explain the pattern of hydrocaffeic acid metabolism across the gut 338 Actinobacterial library (Fig. 4F ). Finally, Dadh was the most closely related biochemically 339 characterized homolog to the candidate dehydroxylase (20% amino acid ID), and the putative 340 DOPAC dehydroxylase is also similar (45% amino acid ID) to catechol lignan dehydroxylase 341 (Cldh), an enzyme recently implicated in the dehydroxylation of the lignan dmSECO in 342
Gordonibacter (42) (table S9) . Though this functional assignment awaits biochemical 343 confirmation, we propose that the highest upregulated enzyme across our two independent datasets 344 is the DOPAC dehydroxylase. Interestingly, unlike with the Eggerthella dehydroxylases, tungstate 345 did not inhibit dehydroxylation of DOPAC by G. pamelaeae (fig. S14 ). This may be explained if 346 the dehydroxylating enzyme can use both molybdenum and tungsten for catalysis, as is seen in 347 certain closely-related enzymes (43) . 348
Despite being expected to perform the same type of chemical reaction, the putative 349 dehydroxylases from E. lenta and G. pamelaeae differ from each other in sequence identity, 350 genomic context, and predicted subunit composition (table S9 and Specificity of dehydroxylase regulation and activity in E. lenta A2. E. lenta A2 was grown 366 anaerobically in BHI medium containing 1 % arginine and 10 mM formate. 0.5 mM of catechol 367 was added to induce dehydroxylase expression, followed by anaerobic lysis and enzyme assays. 368 Crude lysates were exposed to different substrates (500 µM) and reactions were allowed to proceed 369 anaerobically for 20 hours. Assays mixtures were analyzed using LC-MS. Heat map represents the 370 mean of three biological replicates. B) Specificity of DOPAC dehydroxylase regulation and 371 activity in G. pamelaeae A2. G. pamelaeae 3C was grown anaerobically in BHI medium 372 containing 10 mM formate. 0.5 mM of catechol was added to induce dehydroxylase expression, 373 followed by anaerobic lysis and enzyme assays. Crude lysates were exposed to different substrates 374 (500 µM) and reactions were allowed to proceed anaerobically for 20 hours. belongs to the xanthine oxidase family of molybdenum-dependent enzymes, the catechol 399 dehydroxylases belong to the bis-MGD family of molybdenum-dependent enzymes, suggesting 400 independent evolutionary origins (31, (33) (34) . Further phylogenetic analysis revealed that catechol 401 dehydroxylases form a unique clade within the bis-MGD enzyme family, clustering away from the 402 pyrogallol hydroxytransferase (Pht), the only other bis-MGD enzyme known to modify the 403 aromatic ring of a substrate (46) ( Fig. 5A and table S13 ). The catechol dehydroxylases are instead 404 most closely related to acetylene hydratase, an enzyme that adds water to acetylene to provide a 405 carbon source for the marine Proteobacterium Pelobacter acetylenicus (Fig. 6A) (34, (47) (48) . 406
Consistent with this phylogenetic analysis, a sequence similarity network (SSN) analysis using 407 sequences of bis-MGD enzymes revealed distinct clusters of catechol dehydroxylases, further 408 suggesting these enzymes are functionally distinct from known family members (fig. S16 ). The 409 clustering of the dehydroxylases on the SSN did not reflect the phylogeny of the organisms because 410 sequences from both Eggerthella and Gordonibacter were widely distributed across clusters 411 containing distinct, biochemically characterized enzymes ( fig. S16 ). In addition, we found that the 412 two dehydroxylase clusters contained sequences from organisms other than Eggerthella and 413
Gordonibacter (fig. S16 ). Based on these data, we propose that catechol dehydroxylases belong to 414 a distinct group of molybdenum-dependent enzymes. 415
To assess whether this enzyme group harbors greater diversity than the enzymes described 416 in this study, we queried the NCBI nucleotide database and our collection of Actinobacterial 417 genomes for homologs of the Eggerthella and Gordonibacter catechol dehydroxylases. 418
Phylogenetic analyses of the enzyme sequences revealed a large diversity of putative 419 dehydroxylases, including numerous uncharacterized sequences encoded in both Gordonibacter 420 and Eggerthella genomes (Fig. 5B ). This highlights that catechol dehydroxylases likely have 421 diversified within these closely related gut Actinobacteria and that many substrate-enzyme pairs 422 remain to be discovered. Our phylogenetic analysis also revealed that catechol dehydroxylases are 423 not restricted to human-associated Actinobacteria and appear to be part of a larger group of bis-424 MGD enzymes present in diverse bacteria and even Archaea (Fig. 5B ). These organisms come 425 from mammal-associated, plant-associated, soil, and aquatic habitats. Notable organisms encoding 426 putative dehydroxylases include soil-dwelling Streptomycetes (49, 50) , the industrially important 427
anaerobe Clostridium ljungdahlii (51) , and a large number of anaerobic bacterial genera known 428 for their ability degrade aromatic compounds, including Azoarcus, Thauera, Desulfobacula, 429
Geobacter, Desulfumonile, and Desulfitobacterium (Fig. 5B) (52) (53) (54) (55) (56) (57) (58) (59) . Some sequences are shared 430 between gut and environmental microbes, raising questions about the evolutionary processes 431 driving this diversity (Fig. 5B) . 432
As the vast majority of dehydroxylase homologs remain uncharacterized, it is difficult to 433 assign the biochemical activities of the major clades and define the characteristic features of these 434 enzymes. However, we are confident that at least some portion of the sequences captured in this 435 analysis are true catechol dehydroxylases. First, we found that representatives sequences from 436 across our phylogenetic tree are more closely related to acetylene hydratase and the Gordonibacter 437 and Eggerthella dehydroxylases than to any other member of the bis-MGD enzyme family, 438 indicating shared evolutionary origins (table S14 and figs. S17 and S18). Moreover, we noticed 439 that recent genetic studies have implicated some homologs from environmental bacteria in 440 catechol dehydroxylation. For instance, two catechol dehydroxylase homologs from Streptomyces 441 are present in biosynthetic gene clusters that produce the potent anti-tumor compounds 442 yatakemycin and CC-1065 (49,50) ( Fig 5B) . Gene knock-out and complementation studies 443 revealed that the dehydroxylase homolog is essential for CC-1065 production and likely catalyzes 444 reductive dehydroxylation of a late-stage biosynthetic intermediate (49) . Another homolog is 445 present in the 3,5-dihydroxybenzoate (3,5-DHB) degradation operon within the anaerobic soil 446
Proteobacterium Thaeura aromatica (Fig. 5B ). Strains lacking this enzyme exhibit impaired 447 growth on 3,5-DHB as a sole carbon source, suggesting a possible role for this enzyme in 448 metabolizing the one of the two catecholic intermediates involved in this pathway (58, (60) (61) . 449
Based on this analysis, we conclude that the catechol dehydroxylases harbor vast uncharacterized 450 diversity that contributes to both primary and secondary metabolic pathways in habitats beyond 451 the human gut. Our phylogenetic analysis suggested that catechol dehydroxylase activity is present in a 478 range of habitats and phyla, making us curious whether we could detect this metabolism in 479 microbial communities beyond the human gut. As a first step, we explored whether this reactivity 480 was present in gut microbiotas of non-human mammals. We assembled a panel of gut microbiota 481 samples from 12 different mammals representing diverse phylogenetic origins and diets, with 3 482 individuals per mammal (62-63) ( Fig. 7 and fig. S19 ). We cultured these gut communities 483 anaerobically ex vivo, assessed metabolism using a colorimetric assay, and confirmed potential 484 hits using LC-MS/MS ( fig. S15 ). We observed catechol dehydroxylation by at least one of the 485 three individuals for each species across both diet and phylogeny (Fig. 6 ). Hydrocaffeic acid 486 dehydroxylation occurred in >50% of species, while dopamine and (+)-catechin metabolism were 487 observed in 5/12 and 4/12 animals, respectively (Fig. 6 ). Other substrates were metabolized by fewer mammals, including DOPAC, which was only metabolized by the rat gut microbiota. 489
Interestingly, the rat samples had activity towards all compounds tested. While a larger sample 490 size is required to reach clear conclusions about possible links between metabolism of specific 491 catechols and individual mammal gut microbiota, our results clearly demonstrate that catechol 492 dehydroxylation is found in distantly related mammals that have large differences in gut microbial 493 species composition and gene content (62) (63) (64) . Therefore, we conclude that that catechol 494 dehydroxylation is present in a variety of different microbial habitats. For many decades the human gut microbiota has been known to dehydroxylate catechols, 517 but the molecular basis of this enigmatic transformation has remained largely unknown. In this 518 study, we characterized the specificity of the activity and regulation of an enzyme that metabolizes 519 dopamine (Dadh). We then used this knowledge to identify candidate enzymes that dehydroxylate 520 additional host-and plant-derived small molecules. Together, the catechol dehydroxylases 521 represent a new group of molybdenum-dependent enzymes that is present in diverse microbial 522 phyla and environments. Our studies of Dadh revealed a high specificity for catecholamines, 523 supporting the hypothesis that the physiological role of this enzyme is to enable neurotransmitter 524 metabolism by E. lenta. This idea is also consistent with recent observations of gut bacteria using 525 specific neurotransmitters for growth (66) . To our knowledge, Dadh is the first enzyme from a 526 human gut symbiont demonstrated to metabolize catecholamines. However, interactions between 527 catecholamines and intestinal pathogens are well-characterized and have long been known as key 528 players in virulence and infection (67) (68) . Whereas pathogenic organisms such as Y. 529 enterocolitica, E. coli and S. enterica require the intact catechol group of dopamine and 530 norepinephrine to sequester iron and boost growth (67-70), E. lenta dehydroxylates the catechol 531 and likely uses it as an electron acceptor. Thus, Dadh might represent a novel strategy by which 532 gut bacteria take advantage of catecholamines present in the gastrointestinal tract (32,71) 533 Understanding the interplay between pathogenic and commensal interactions with catecholamines 534 is an intriguing avenue for further research. 535
In addition to characterizing Dadh, we discover candidate dehydroxylases that metabolize 536 (+)-catechin, hydrocaffeic acid, and DOPAC. Further biochemical studies are important for 537 validating the activities of these enzymes, but our preliminary data support a working model in 538 which catechol dehydroxylation is performed by enzymes that are specialized for individual 539 substrates. We identified large numbers of uncharacterized dehydroxylases in Eggerthella and 540 Gordonibacter (Fig. 5B ), hinting at an expansion of this group of enzymes among human gut 541 Actinobacteria. While it remains to be seen whether these uncharacterized enzymes are also 542 specific for distinct substrates, this type of diversification of closely related enzymes indicates a 543 potentially important role for catechol dehydroxylation in the human gut microbiota. Expansion 544 of enzyme families within specific clades of gut microbes is well-characterized in the context of 545 polysaccharide metabolism. For example, human gut Bacteroides isolates harbor hundreds of 546 polysaccharide utilization loci but upregulate only a subset of genes in response to distinct 547 substrates (72) (73) (74) (75) . This transcriptional regulation and biochemical specificity enables utilization 548 of host-or plant-derived carbon sources depending on their availability (76) (77) (78) . The diversity of 549 catechol dehydroxylases might have evolved in a similar manner, providing a biochemical arsenal 550 that enables Actinobacteria to use a range of different electron acceptors whose availability 551 depends on the diet or physiology of the host. Identifying the functions of uncharacterized catechol 552 dehydroxylases could shed light the adaptation of gut organisms to small molecules produced and 553 ingested by the host. 554
In addition to uncovering the diversity of dehydroxylases among human gut bacteria, our 555 study illustrates the chemical strategies used to enable microbial survival and interactions in the 556 human gut may be relevant to a broad range of species and habitats. While mammalian gut 557 microbiomes have previously been compared in terms of gene content and species composition 558 (63) (64) (65) , our study provides functional evidence for conservation of specific gut microbial 559 metabolic pathways across distinct hosts. While this hints at a potentially important role of catechol 560 dehydroxylation among mammalian gut communities, the distribution of putative dehydroxylases 561 among environmental microbes suggests the relevance of this chemistry likely extends to many 562 additional microbial habitats. The shared metabolic capabilities between gut and environmental 563 microbes reinforces findings from recent studies of gut microbial enzymes. For example, gut 564 microbial carbohydrate-degrading enzymes and glycyl radical enzymes that play important roles 565 in degrading diet-derived polysaccharides, amino acids, and osmolytes in the human gut can also 566 be found among environmental isolates (74, (79) (80) (81) . Enzyme discovery in the human gut 567 microbiota therefore not only has implications for improving human health and disease, but also 568 for discovering novel catalytic functions and metabolic pathways broadly relevant to microbial 569 life. Our study now sets the stage for further investigations of the chemical mechanisms and 570 biological consequences of catechol dehydroxylation in the human body and beyond. 571
Finally, our findings provide a framework for linking metabolic transformations performed 572 by complex gut microbial communities to individual strains, genes, and enzymes. Our broad 573 exploration of a class of metabolic transformations contrasts with the more common focus on 574 metabolism of individual drugs or dietary compounds (29, 6, (79) (80) (81) (82) (83) . This functional group-575 focused approach may greatly increase the efficiency with which we can link metabolic activities 576 to microbial genes and enzymes. We envision that related experimental workflows could find 577 broad utility in the discovery of gut microbial enzymes catalyzing other widespread, biologically 578 significant reactions, including reductive metabolism of additional functional groups that are 579 prevalent in diverse molecules encountered by the gut microbiota (1). 580
General materials and methods 582 583
The following chemicals were used in this study: tetracycline (Sigma Aldrich, 
